A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials

AIM: To evaluate health-related quality of life (health utility) scores in patients with diabetes receiving insulin degludec (IDeg) or insulin glargine (IGlar). METHODS: Patient-level data from six, randomized, controlled, open-label, multicentre, confirmatory, treat-to-target trials of 26- or 52 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Freemantle, N, Evans, M, Christensen, T, Wolden, M L, Bjorner, J B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298030/
https://www.ncbi.nlm.nih.gov/pubmed/23451759
http://dx.doi.org/10.1111/dom.12086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298030/
https://www.ncbi.nlm.nih.gov/pubmed/23451759
http://dx.doi.org/10.1111/dom.12086

Ejemplares similares